Hikma Pharmaceuticals (HIK)

 
 

Share Price

Bid Price High Price
Ask Price Low Price
Open Price Spread
Prev Close Volume

Hikma Pharmaceuticals Historic Prices

Date Open High Low Close Volume
Nov 17, 2017 1,020.00 1,043.00 999.00 1,041.00 1,049,412
Nov 16, 2017 958.00 1,022.00 958.00 1,021.00 1,138,619
Nov 15, 2017 950.00 967.50 943.00 959.00 989,252
Nov 14, 2017 944.50 986.51 906.50 949.50 1,595,505
Nov 13, 2017 992.00 999.50 954.00 960.50 1,404,662
More Hikma Pharmaceuticals Historic Prices >
Intraday
Historic - 1 year
Advanced Hikma Pharmaceuticals Charts >

Hikma Pharmaceuticals Share Information

Company Name Hikma Pharmaceuticals Epic HIK
ISIN GB00B0LCW083 Index FTSE 250
EMS 1,000 Prev Close 1,041.00
Shares in Issue (m) 240.66 Market Cap (£m) 2,457.09
PE Ratio 15.35 Div per Share (p) 33.00
Div Yield 2.07 Div Cover 2.02
EPS 66.50 EPS Growth (%) -47.47
PEG -0.32 DPS Growth (%) 3.13
ROCE 6.10 Net Gearing 41.19
Quick Ratio 1.08 Current Ratio 1.58

Hikma Pharmaceuticals Broker Views

Date Broker Recomm. Price Old Target New Target Notes
14 Nov Peel Hunt Hold 1,041.00 - 1,390.00 Reiterates
10 Nov JP Morgan Cazenove Neutral 1,041.00 1,250.00 1,000.00 Reiterates
10 Nov HSBC Reduce 1,041.00 1,060.00 865.00 Reiterates
09 Nov Peel Hunt Hold 1,041.00 - - Reiterates
09 Nov Jefferies International Hold 1,041.00 1,045.00 1,045.00 Reiterates
More Hikma Pharmaceuticals Broker Views >

Hikma Pharmaceuticals Director Deals

Date Director Type Volume / Price Trade Value
31 May 2017 Mazen Darwazah Transfer In 38,088 @ 0.00p £0.00
31 May 2017 Said Darwazah Transfer In 52,164 @ 0.00p £0.00
15 May 2017 Mazen Darwazah Transfer In 30,000 @ 0.00p £0.00
15 May 2017 Said Darwazah Transfer In 41,000 @ 0.00p £0.00
20 Dec 2016 Ali Al-Husry Buy 140,730 @ 1,827.00p £2,571,137.10
More Hikma Pharmaceuticals Director Deals >

Hikma Pharmaceuticals Events

Date Event Type
06 Apr 2017 Ex-Dividend
19 May 2017 Trading Statement
17 Aug 2017 Interim Result
24 Aug 2017 Ex-Dividend
09 Nov 2017 Trading Statement
More Hikma Pharmaceuticals events >

Hikma Pharmaceuticals News